These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25180409)

  • 21. Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I.
    Basta G; Del Turco S; Marchi F; Navarra T; Battaglia D; Mercuri A; Mazzone A; Berti S
    Coron Artery Dis; 2011 Dec; 22(8):590-4. PubMed ID: 22072229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study.
    Tajsic M; Járai R; Koch J; Stangl K; Wojta J; Dreger H; Huber K
    Int J Cardiol; 2018 Dec; 273():243-248. PubMed ID: 30282602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome.
    Demir MT; Baydin A; Amanvermez R; Erenler AK; Güzel M; Yücel O
    Bratisl Lek Listy; 2018; 119(8):509-512. PubMed ID: 30160160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.
    Marino R; Magrini L; Orsini F; Russo V; Cardelli P; Salerno G; Hur M; Di Somma S;
    Ann Lab Med; 2017 Mar; 37(2):137-146. PubMed ID: 28029000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
    Keller T; Zeller T; Ojeda F; Tzikas S; Lillpopp L; Sinning C; Wild P; Genth-Zotz S; Warnholtz A; Giannitsis E; Möckel M; Bickel C; Peetz D; Lackner K; Baldus S; Münzel T; Blankenberg S
    JAMA; 2011 Dec; 306(24):2684-93. PubMed ID: 22203537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery.
    Eigel P; van Ingen G; Wagenpfeil S
    Eur J Cardiothorac Surg; 2001 Sep; 20(3):544-9. PubMed ID: 11509277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?
    Anders B; Alonso A; Artemis D; Schäfer A; Ebert A; Kablau M; Fluechter S; Findeisen P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 36(3):211-7. PubMed ID: 24135532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.
    Korley FK; Schulman SP; Sokoll LJ; DeFilippis AP; Stolbach AI; Bayram JD; Saheed MO; Omron R; Fernandez C; Lwin A; Cai SS; Post WS; Jaffe AS
    Acad Emerg Med; 2014 Jul; 21(7):727-35. PubMed ID: 25112512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of early cardiac troponin I to predict long-term adverse events after coronary artery bypass graft surgery in patients presenting with acute coronary syndromes.
    Amin AP; Mukhopadhyay E; Napan S; Mamtani M; Kelly RF; Kulkarni H
    Clin Cardiol; 2009 Jul; 32(7):386-92. PubMed ID: 19609893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical performance of a new point-of-care cardiac troponin I test.
    Christ M; Geier F; Blaschke S; Giannitsis E; Khellaf M; Mair J; Pariente D; Scharnhorst V; Semjonow V; Hausfater P
    Clin Chem Lab Med; 2018 Jul; 56(8):1336-1344. PubMed ID: 29630502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis.
    Kvisvik B; Mørkrid L; Røsjø H; Cvancarova M; Rowe AD; Eek C; Bendz B; Edvardsen T; Gravning J
    Clin Chem; 2017 Feb; 63(2):552-562. PubMed ID: 27974383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of Ortho Clinical Diagnostics high-sensitivity cardiac Troponin I assay in patients with symptoms suggestive of acute coronary syndrome.
    Kavsak PA; Mondoux SE; Sherbino J; Ma J; Clayton N; Hill SA; McQueen M; Mehta SR; Griffith LE; Devereaux PJ; Worster A
    Clin Biochem; 2020 Jun; 80():48-51. PubMed ID: 32304695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
    Bonaca MP; O'Malley RG; Murphy SA; Jarolim P; Conrad MJ; Braunwald E; Sabatine MS; Morrow DA
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):431-40. PubMed ID: 25538086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
    Eggers KM; Lagerqvist B; Oldgren J; Venge P; Wallentin L; Lindahl B
    Am Heart J; 2008 Sep; 156(3):588-94. PubMed ID: 18760145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
    Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
    J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study.
    Sánchez-de-la-Torre A; Soler X; Barbé F; Florés M; Maisel A; Malhotra A; Rue M; Bertran S; Aldomá A; Worner F; Valls J; Lee CH; Turino C; Galera E; de Batlle J; Sánchez-de-la-Torre M;
    Chest; 2018 Feb; 153(2):329-338. PubMed ID: 28736306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Troponin really a reliable marker in patients with acute ischemic stroke?
    Yildiz Z; Koçer A; Avşar Ş; Cinier G
    Rom J Intern Med; 2018 Dec; 56(4):250-256. PubMed ID: 29894304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Doerr S; Keller T; Blankenberg S; Katus HA; Giannitsis E
    Clin Chem; 2012 Jan; 58(1):209-18. PubMed ID: 22134520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.